Moti L. Kashyap

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events

Sander J. Robins, Dorothea Collins, Janet Wittes et al. · JAMA · 2001 · 925 citations

Medicine, Pharmacology, Pharmacotherapy +16

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Interchange of Apolipoproteins between Chylomicrons and High Density Lipoproteins during Alimentary Lipemia in Man

Richard J. Havel, John P. Kane, Moti L. Kashyap · Journal of Clinical Investigation · 1973 · 529 citations · Full text

Life Sciences, Biochemistry, Nutritional Sciences +17

Relationship of Apolipoproteins A-1 and B, and Lipoprotein(a) to Cardiovascular Outcomes

John J. Albers, April Slee, Kevin D. O’Brien et al. · Journal of the American College of Cardiology · 2013 · 312 citations

Life Sciences, Biochemistry, Cardiology +14